ALB and gallbladder cancer: In Zhan's study of gallbladder cancer, the MiniPDX model was established using freshly resected primary lesions from 12 patients with gallbladder to examine the sensitivity of five of the most commonly used chemotherapeutic agents, namely, gemcitabine, oxaliplatin, 5-fluorouracil, nanoparticle albumin-bound (nab) paclitaxel, and irinotecan.